Haemonetics Says CSL Plasma to Complete Rollout of Products by End-2027
MT newswire2026/10/08 16:3412:34 PM EDT, 10/08/2026 (MT Newswires) -- Haemonetics (HAE) said in a filing Thursday that CSL Plasma expects to complete the rollout of Haemonetics' devices and disposables by the end of 2027. CSL expects all of its US plasma collection centers to transition to Haemonetics products, although the scope and timing of the rollout could change, according to the filing with the US Securities and Exchange Commission. Haemonetics said its fiscal 2027 guidance is unchanged and that it expects to provide an update on the anticipated impact of its supply agreement with CSL during its fiscal Q2 earnings call in November. Shares of Haemonetics were up 15.6% in Thursday trading. Price: 117.60, Change: +15.89, Percent Change: +15.62
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.
Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF
Crypto prices
More
